Applied BioCode Corporation (6598.TW)

TWD 20.35

(-0.97%)

Revenue Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual revenue in 2023 was 395.16 Million TWD , up 1.25% from previous year.
Applied BioCode Corporation's latest quarterly revenue in 2024 Q2 was 101.63 Million TWD , up 24.7% from previous quarter.
Applied BioCode Corporation reported a annual revenue of 390.3 Million TWD in annual revenue 2022, up 21.98% from previous year.
Applied BioCode Corporation reported a annual revenue of 319.96 Million TWD in annual revenue 2021, up 7.01% from previous year.
Applied BioCode Corporation reported a quarterly revenue of 81.5 Million TWD for 2024 Q1, down -36.44% from previous quarter.
Applied BioCode Corporation reported a quarterly revenue of 128.22 Million TWD for 2023 Q4, up 21.25% from previous quarter.

Annual Revenue Chart of Applied BioCode Corporation (2023 - 2013)

Historical Annual Revenue of Applied BioCode Corporation (2023 - 2013)

Year	Revenue	Revenue Growth
2023	395.16 Million TWD	1.25%
2022	390.3 Million TWD	21.98%
2021	319.96 Million TWD	7.01%
2020	299.01 Million TWD	185.61%
2019	104.69 Million TWD	181.85%
2018	37.14 Million TWD	38.83%
2017	26.75 Million TWD	127.52%
2016	11.76 Million TWD	-49.42%
2015	23.24 Million TWD	53.08%
2014	15.18 Million TWD	-42.95%
2013	26.61 Million TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	101.63 Million TWD	24.7%
2024 Q1	81.5 Million TWD	-36.44%
2023 Q4	128.22 Million TWD	21.25%
2023 FY	395.16 Million TWD	1.25%
2023 Q1	82.7 Million TWD	-31.5%
2023 Q2	78.47 Million TWD	-5.12%
2023 Q3	105.75 Million TWD	34.75%
2022 FY	390.3 Million TWD	21.98%
2022 Q1	54.05 Million TWD	-50.65%
2022 Q4	120.73 Million TWD	12.04%
2022 Q3	107.76 Million TWD	0.01%
2022 Q2	107.75 Million TWD	99.35%
2021 Q4	109.52 Million TWD	86.34%
2021 Q2	67.79 Million TWD	-19.16%
2021 Q1	83.86 Million TWD	-39.45%
2021 FY	319.96 Million TWD	7.01%
2021 Q3	58.77 Million TWD	-13.31%
2020 FY	299.01 Million TWD	185.61%
2020 Q4	138.5 Million TWD	42.2%
2020 Q3	97.4 Million TWD	733.8%
2020 Q2	11.68 Million TWD	-77.28%
2020 Q1	51.41 Million TWD	99.15%
2019 Q3	33.47 Million TWD	73.47%
2019 FY	104.69 Million TWD	181.85%
2019 Q1	26.09 Million TWD	54.89%
2019 Q2	19.29 Million TWD	-26.06%
2019 Q4	25.81 Million TWD	-22.88%
2018 Q2	7.9 Million TWD	0.0%
2018 FY	37.14 Million TWD	38.83%
2018 Q4	16.85 Million TWD	275.45%
2018 Q3	4.48 Million TWD	-43.22%
2018 Q1	7.9 Million TWD	-7.42%
2017 Q3	8.53 Million TWD	76.35%
2017 Q2	4.84 Million TWD	0.0%
2017 Q4	8.53 Million TWD	0.0%
2017 Q1	4.84 Million TWD	0.0%
2017 FY	26.75 Million TWD	127.52%
2016 Q4	- TWD	0.0%
2016 Q2	1.65 Million TWD	0.0%
2016 FY	11.76 Million TWD	-49.42%
2015 FY	23.24 Million TWD	53.08%
2015 Q4	- TWD	0.0%
2014 FY	15.18 Million TWD	-42.95%
2013 FY	26.61 Million TWD	0.0%

Peer Revenue Comparison of Applied BioCode Corporation

Name	Revenue	Revenue Difference
Excelsior Medical Co., Ltd.	8.23 Billion TWD	95.204%
Apex Medical Corp.	2.64 Billion TWD	85.072%
OK Biotech Co., Ltd.	1.19 Billion TWD	66.848%